Dapsone as an alternative to the treatment of chronic urticaria non-responsive to antihistamines;Dapsona como alternativa no tratamento de urticária crônica não responsiva a anti-histamínicos

Anais Brasileiros de Dermatologia

Volumn 83, Issue 5, 2008, Pages 413-418

  Pires, Juliana Soares ^a,b   De Ue, Ana Paula Fusel ^a   Furlani, Wellington De Jesus ^a   De Souza, Patrícia Karla ^a   Rotta, Osmar ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Dapsone; Histamine H1 antagonists; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; DAPSONE;

ADULT; ARTICLE; CHRONIC DISEASE; CHRONIC URTICARIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HISTOLOGY; HUMAN; LONG TERM CARE; MALE; MEDICAL RECORD REVIEW; OUTPATIENT DEPARTMENT; QUALITY OF LIFE; RETROSPECTIVE STUDY; SYMPTOM; TREATMENT RESPONSE;

EID: 58849160954     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962008000500003     Document Type: Article

References (20)

1. Kozel MMA, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs. 2004;64:2515-36.
2. Tharp MD. Chronic urticaria: pathophysiology and treatment approaches. J Allergy Clin Immunol. 1996;98:S325-30.
3. Grattan CEH, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol. 2002;46:645-57.
4. Grattan CEH. The urticaria spectrum: recognition of clinical patterns can help management. Clin Exp Dermatol. 2004;29:217-21.
5. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CEH, Greaves MW, Henz BM, et al. EAACI/GA2 LEN/EDF guideline: management of urticaria. Allergy. 2006;61:321-31.
6. Dibbern DA Jr, Dreskin SC. Urticaria and angioedema: an overview. Immunol Allergy Clin North Am. 2004;24:141-62.
7. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136:197-201.
8. Baiardini I, Giardini A, Pasquali M, Dignetti P, Guerra L, Specchia C, et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy. 2003;58:621-3.
9. Tedeschi A, Airaghi L, Lorini M, Asero R. Chronic urticaria: a role for newer immunomodulatory drugs? Am J Clin Dermatol. 2003;4:297-305.
10. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001;45:420-34.
11. Wolf R, Tüzün B, Tüzün Y. Dapsone: unapproved uses or indications. Clin Dermatol. 2000;18:37-53.
12. Muramatsu C, Tanabe E. Urticarial vasculitis: response to dapsone and colchicine. J Am Acad Dermatol. 1985;13:1055.
13. Nürnberg W, Grabbe J, Czarnetzki BM. Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol. 1995;75:54-6.
14. Fortson JS, Zone JJ, Hammond E, Groggel GC. Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone. J Am Acad Dermatol. 1986;15:1137-42.
15. Sago J, Hall RP. Dapsone. Dermatol Ther. 2002;15:340-51.
16. Boehm I, Bauer R, Bieber T. Urticaria treated with dapsone. Allergy. 1999;54:765-6.
17. Dayani A, Gould DJ, Cambell S. Delayed pressure urticaria: treatment with dapsone. J Dermatol Treat. 1992;3:61-2.
18. Cassano N, D'Argento V, Filotico R, Vena GA. Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study. Acta Derm Venereol. 2005;85:254-5.
19. Engin B, Özdemir M. Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol. 2008;22:481-6.
20. Criado RFJ, Criado PR, Martins JEC, Valente NYS, Michalany NS, Vasconcellos C. Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features. J Dermatol Treat. 2008;19:92-6.